CASES OF CHURG-STRAUSS SYNDROME IN PATIENTS RECEIVING MONTELUKAST
Abstract
Churg-Strauss syndrome is а rare disorder, but in patients with asthma it may develop as an adverse effect of the administered drugs. The aim of this study was to investigate possible causal relationship between montelukast and the occurrence of Churg-Strauss syndrome. Medical literature was reviewed by searching the databases “Medline” and “Googlescholar”, in order to detect published cases of Churg-Strauss syndrome associated with use of montelukast. In this article is included 13 publications which contain the following keywords: montelukast, Churg-Strauss syndrome and side effects. Relationship between use of montelukast and development of Churg-Strauss syndrome was not clearly causal, although montelukast was associated with development and relapse of the syndrome. This fact supports the hypothesis that leukotriene antagonists are involved in the pathogenesis of this serious disease. Special attention should be paid to appearance of new symptoms in an asthmatic patient, already treated with corticosteroids, who start receiving leukotriene antagonists, especially if the dose of corticosteroids is reduced. Definitive confirmation or rejection of the hypothesis that leukotriene antagonists are directly involved in the development of this syndrome require further investigations.
References
Solans R, Bosch JA, Selva A, Orriols R, Vilardell M. Montelukast and Churg Strauss syndrome. Thorax 2002; 57: 183-5.
Rang HP, Dale MM, Ritter JM et al. Farmakologija. Prvo srpsko izdanje. Beograd 2005.
Noth I, Strek ME, Left AR. Churg-Stauss syndrome. Lancet 2003; 361: 587-94.
Eustace JA, Nadasdy T, Choi M. The Churg-Strauss syndrome. J Am Soc Nephrol 1999; 10: 2048-55.
Sablé-Fourtassou R, Cohen P, Mahr A. Antineutrophil Cytoplasmic Antibodies and the Churg-Strauss syndrome. Annals of Internal Medicine 2005; 143: 632-40.
Conron M, Beynon HLC. Churg-Strauss syndrome. Thorax 2000; 55: 870-7.
Cottin V, Cordier JF. Churg-Strauss syndrome. Allergy 1999; 54: 535-51.
Solans R, Bosch JA, Selva A, Orriols R, Vilardell M, Montelukast and Churg Strauss syndrome. Thorax 2002; 57: 183-5.
Guilpain P, Viallard JF, Lagarde P, Cohen P, Kambouchner M, Pellegrin JL, Guillevin L, Churg Strauss syndrome in two patients receiving montelukast, Rheumatology Oxford 2002; 41(5): 535-9.
Franco J, Artés MJ. Pulmonary eosinophilia associated with montelukast. Thorax 1999; 54: 558-60.
Atef BM, Murphy D. Montelukast-associated Churg-Strauss syndrome. Age and ageing 2003; 32: 551-2.
Villena V, Hidalgo R, Sotelo MT, Escribano M. Montelukast and Churg Strauss syndrome. Eur Respir J 2000; 15: 626.
Conen D, Leuppi J, Bubendorf L, Ronsdorf A, Tamm M, Hauser T. Montelukast and Churg-Strauss syndrome. Swiss Med 2004; 134: 377-80.
Mukhopadhyay A, Stanley NN, Churg Strauss syndrome associated with montelukast, Postgrad Med J 2001; 77: 390-391.
Félix JS, Pereiro A, Salas A. Tratamiento del asma con antileucotrienos y syndrome de Churg Strauss. Arch Bronconeumol 2001; 37: 48-50.
Perez de Llano LA, Veres Racamande A, Pana Arrondo A. Churg Strauss syndrome in an asthmatic man treated with montelukast:continued controversy. Arch Broncopneumol 2002; 38: 251-2.
R.Cuchacovich, M.Justniano, L.R.Espinoza, Churg Strauss syndrome associated with leukotriene receptor antagonists, Clin Rheumatol 2007; 26: 1769-71.
Wechsler ME, Finn D, Gunawardena D et al. Churg Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000; 117: 708.
Tuggey JM, Hoskar HSR, Churg Strauss syndrome associated with montelukast therapy, Thorax 2000; 55: 805-6.
Girszyn N, Amiot N, Luverier A, Courvile P, Marie I. Churg Strauss associated with montelukast therapy. QJM 2008; 101: 669-71.
Solans R, Bosch JA, Perez-Bocanegra C et al. Churg Strauss syndrome: outcome and long-term follow up of 32 patients. Rheumatology Oxford 2011; 40: 763-71.
Alfaro TM, Duarte C, Monteiro R, Simão A, Nascimento Costa JM. Churg-Strauss syndrome: Case Series. Rev Port Pneumol 2012; 18: 86-92.